Yi Du

  • 1459 Citations
  • 17 h-Index
20072019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yi Du is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1459 Citations
  • 17 h-Index
  • 23 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Review article

EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis

An, J., Du, Y., Fan, X., Wang, Y., Ivan, C., Zhang, X. G., Sood, A. K., An, Z. & Zhang, N., Mar 21 2019, In : Oncogene. 38, 12, p. 2123-2134 12 p.

Research output: Contribution to journalArticle

  • 4 Scopus citations

    EGFR and c-Met cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma

    Dong, Q., Du, Y., Li, H., Liu, C., Wei, Y., Chen, M. K., Zhao, X., Chu, Y. Y., Qiu, Y., Qin, L., Yamaguchi, H. & Hung, M. C., Feb 15 2019, In : Cancer Research. 79, 4, p. 819-829 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism

    Chen, M. K., Du, Y., Sun, L., Hsu, J. L., Wang, Y. H., Gao, Y., Huang, J. & Hung, M. C., May 24 2019, In : Journal of Biological Chemistry. 294, 21, p. 8516-8528 13 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1

    Li, H., Li, C. W., Li, X., Ding, Q., Guo, L., Liu, S., Liu, C., Lai, C. C., Hsu, J. M., Dong, Q., Xia, W., Hsu, J. L., Yamaguchi, H., Du, Y., Lai, Y. J., Sun, X., Koller, P. B., Ye, Q. & Hung, M. C., May 2019, In : Gastroenterology. 156, 6, p. 1849-1861.e13

    Research output: Contribution to journalArticle

  • 17 Scopus citations

    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

    Yamaguchi, H., Du, Y., Nakai, K., Ding, M., Chang, S. S., Hsu, J. L., Yao, J., Wei, Y., Nie, L., Jiao, S., Chang, W. C., Chen, C. H., Yu, Y., Hortobagyi, G. N. & Hung, M. C., Jan 11 2018, In : Oncogene. 37, 2, p. 208-217 10 p.

    Research output: Contribution to journalArticle

  • 19 Scopus citations